The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Ovarian Serous Cystadenocarcinoma.

Ovarian serous cystadenocarcinoma (OV) is one of the deadliest gynecologic cancers, primarily due to late-stage diagnosis and limited treatment options. Precision oncology seeks to personalize cancer treatment based on individual genetic profiles and…

Preview only. Read the full abstract at the source